Negative-pressure drainage vs. duct stenting to prevent pancreatitis after papillectomy
Part of Cancer, Digestive system clinical trials.
This trial compares two methods to prevent pancreatitis after endoscopic removal of duodenal papillary tumors. It tests whether using a negative-pressure drain tube is better than placing a stent in the pancreatic duct.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a noncancerous tumor or very early-stage cancer (limited to the top layer) in the duodenal papilla.
- You are scheduled for endoscopic removal of the tumor.
- The tumor is not larger than 40 mm, is not next to a duodenal pouch, and does not extend far into the pancreatic or bile ducts.
- You do not have a genetic condition called familial adenomatous polyposis (FAP).
- You do not have severe heart or lung disease that would make anesthesia or the procedure risky.
- You do not have a bleeding disorder or take blood thinners that can't be stopped.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of surgery to remove tumors that start near the pancreas but not in it. The goal is to see if a newer, less invasive method works as well as the standard approach, which may mean fewer cuts and a faster recovery.
This trial compares placing a small plastic drain (stent) in your pancreas duct versus usual care for people with severe acute pancreatitis that is starting to cause organ failure. The goal is to see if the stent helps you heal faster and prevents complications.
This trial tests placing a small plastic tube (stent) in your pancreatic duct early during ERCP to try to prevent pancreatitis (inflammation of the pancreas). It’s for people having their first ERCP to get into their bile duct.
This study tests whether placing an external pancreatic duct stent after pancreaticoduodenectomy can lower the risk of pancreatic leak (pancreatic fistula). If you had this surgery with a specific connection technique, you may be able to help find a safer way to prevent complications.
This trial compares a modified surgical technique to the standard one for removing pancreatic tumors. It aims to see if the new method lowers the risk of a leak from the pancreas after surgery.
This study looks at whether placing a small tube (a pancreatic stent) during an ERCP procedure can lower the chance of getting pancreatitis afterward. If you need a difficult ERCP with bile duct access, the results may help improve prevention of post-procedure pancreatitis.
Hear when a new Ampullary Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.